| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |